New medical warning: These drugs age you up to 10 years faster

Bars like Ozempic, Wegovy and Mounjaro have become extremely familiar due to rapid results in weight loss, but new studies reveal a disturbing cost of this “success”.

These drugs operate by targeting the appetite receptors in the brain, creating a sense of saturation, resulting in smaller intake of food and weight loss. Although Ozempic is primarily the drug for type 2 diabetes, its effects on weakening have led to widespread use for this purpose.

In addition to the already known side effects as hair loss, digestive problems, and dependent skin, however, recent studies point to a more serious problem.

Losing muscles equals a decade of aging

Report Canadian researchers, conducted in collaboration with Les Mills and UKActiv, found that people using these drugs lose a considerable amount of muscle mass. This loss, they say, is equivalent to about ten years of aging, putting middle-aged users at risk of increased fragility and fall injury.

The report further points out: “muscle loss is particularly disturbing for the elderly, as muscle mass falls naturally with age. Loss of muscle and bone mass related to weakened drugs can also increase the fragility and risk of falling. ”

It is warned that without sufficient muscle - building training, this situation can become dangerous, it transmitsgraphy.

Experts ' Thought

The principal author of the study, Dr. Jillian Hatfield, associate professor at the Fraser Valley University in Canada, explained the size of the problem. Her study revealed that participants who exercised 150 minutes a week and consumed 500 calories less than recommended lost about 11 percent of their muscle mass. She explained that similar muscle loss occurs after baratric surgery, cancer treatment, and during the natural aging process of a 10-year period.

Bryce Hastings, director of research at Les Mills, stressed that people who take weakened drugs should regularly engage in force training to counter muscle loss. However, he noted that more studies are needed to understand fully the impact of such drugs.

Producers ' Answer

As LADbible reported, in response to these findings, Novo Nordisk, producer of Ozempic and Wegovy, issued a statement: “Recommanding that patients take these drugs only for their adopted indicators and under the supervision of a health professional. The treatment decisions must be made together with a health professional, who can assess the adaptability of GLP-1 use based on the patient's individual medical profile. ”

“In clinical trials for Wegovy, Ozempic or Rybelsus, we have not specifically studied the effect of the drug on muscle mass. In a sub-tour of 140 patients with BMI to 40, conducted as part of the STEP 1 study, denziometry (DEXA) suggested that treatment with Wegovy was accompanied by lowering both fat and muscle mass, with greater fat than muscle reduction”, they added.

We recommend that all patients who experience side effects during the capture of Wegovy, Ozempic, or Rybelsus contact their healthcare professional”, reports Novo Nordisk.

Eli Lilly, mounjaro producer, also issued a statement: “Patient security is the main priority of the Lilly company. We take seriously all patient safety reports and monitor, evaluate and actively report security information for all our drugs. Mounjaro (trzepatid) should be used only when described by a health professional, and recipes should be issued by pharmacists and licensed distributors. ”

The important thing is that patients maintain a balanced diet and regularly engage in physical activity to support general health, including the preservation of muscle mass. We encourage patients to consult their doctor or health care professionals to discuss any possible side effects they may have and to make sure they are taking the original drugs of Lilly Company. ”